A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Allergan

Status and phase: Completed; Phase 4

Conditions: Hyperhidrosis

Treatments: Biological: Botulinum Toxin Type A

Study type: Interventional

Funder types: Industry

Identifiers

NCT00168480

191622-513

Details and patient eligibility

About

This is a three year open-label study in subjects with axillary hyperhidrosis.

Enrollment: 424 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Marked axillary hyperhidrosis

Exclusion criteria

• Previous use of botulinum toxin for hyperhidrosis

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

424 participants in 1 patient group

1

Experimental group

Description:

Botulinum Toxin Type A

Treatment:

Biological: Botulinum Toxin Type A